AP1891A - HIV immunogenic compositions and methods. - Google Patents

HIV immunogenic compositions and methods.

Info

Publication number: AP1891A
Authority: AP; ARIPO
Prior art keywords: mammal; immunogenic compositions; hiv; iss; adjuvant
Prior art date: 1999-05-06

Application number

APAP/P/2001/002300A

Other languages

English (en)

Other versions

AP2001002300A0 (en

Inventor

Ronald B Moss

Original Assignee

The Immune Response Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-06

Filing date

2000-05-05

Publication date

2008-09-23

2000-05-05 Application filed by The Immune Response Corp filed Critical The Immune Response Corp

2001-12-31 Publication of AP2001002300A0 publication Critical patent/AP2001002300A0/xx

2008-09-23 Application granted granted Critical

2008-09-23 Publication of AP1891A publication Critical patent/AP1891A/en

Links

230000002163 immunogen Effects 0.000 title abstract 7
239000000203 mixture Substances 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 4
241000725303 Human immunodeficiency virus Species 0.000 abstract 8
239000000427 antigen Substances 0.000 abstract 7
102000036639 antigens Human genes 0.000 abstract 7
108091007433 antigens Proteins 0.000 abstract 7
241000124008 Mammalia Species 0.000 abstract 6
239000002671 adjuvant Substances 0.000 abstract 4
230000003308 immunostimulating effect Effects 0.000 abstract 4
102000039446 nucleic acids Human genes 0.000 abstract 4
108020004707 nucleic acids Proteins 0.000 abstract 4
150000007523 nucleic acids Chemical class 0.000 abstract 4
230000002708 enhancing effect Effects 0.000 abstract 2
101710205625 Capsid protein p24 Proteins 0.000 abstract 1
102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 abstract 1
101710091045 Envelope protein Proteins 0.000 abstract 1
101710177166 Phosphoprotein Proteins 0.000 abstract 1
101710188315 Protein X Proteins 0.000 abstract 1
101710149279 Small delta antigen Proteins 0.000 abstract 1
102100022563 Tubulin polymerization-promoting protein Human genes 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

APAP/P/2001/002300A 1999-05-06 2000-05-05 HIV immunogenic compositions and methods. AP1891A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13276299P	1999-05-06	1999-05-06
US15066799P	1999-08-25	1999-08-25
PCT/US2000/012495 WO2000067787A2 (en)	1999-05-06	2000-05-05	Hiv immunogenic compositions and methods

Publications (2)

Publication Number	Publication Date
AP2001002300A0 AP2001002300A0 (en)	2001-12-31
AP1891A true AP1891A (en)	2008-09-23

Family

ID=26830710

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2001/002300A AP1891A (en)	1999-05-06	2000-05-05	HIV immunogenic compositions and methods.

Country Status (8)

Country	Link
EP (1)	EP1176978A2 (es)
AP (1)	AP1891A (es)
AU (1)	AU4992900A (es)
BR (1)	BR0010323A (es)
CA (1)	CA2372960C (es)
CR (1)	CR6491A (es)
OA (1)	OA11937A (es)
WO (1)	WO2000067787A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
DK1733735T3 (en)	1998-05-22	2017-06-19	Ottawa Hospital Res Inst	Methods and products for the induction of mucosal immunity
WO2000039304A2 (en)	1998-12-31	2000-07-06	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1980617A1 (en)	1998-12-31	2008-10-15	Novartis Vaccines and Diagnostics, Inc.	Improved expression of HIV polypeptides and production of virus-like particles
ES2572834T3 (es)	1999-02-17	2016-06-02	Csl Limited	Complejos inmunogénicos y métodos relacionados con los mismos
US6977245B2 (en)	1999-04-12	2005-12-20	The United States Of America As Represented By The Department Of Health And Human Services	Oligodeoxynucleotide and its use to induce an immune response
WO2001000232A2 (en) *	1999-06-29	2001-01-04	Smithkline Beecham Biologicals S.A.	Use of cpg as an adjuvant for hiv vaccine
EP1322655B1 (en)	2000-01-14	2007-11-14	The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services	Oligodeoxynucleotide and its use to induce an immune response
NZ526322A (en)	2000-12-27	2005-06-24	Dynavax Tech Corp	Immunomodulatory polynucleotides and methods of using the same
SG152045A1 (en) *	2001-01-26	2009-05-29	Immune Response Corp Inc	Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
EP1404873B1 (en)	2001-06-21	2013-05-22	Dynavax Technologies Corporation	Chimeric immunomodulatory compounds and methods of using the same
CA2452015C (en)	2001-07-05	2012-07-03	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2003020884A2 (en)	2001-08-14	2003-03-13	The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services	Method for rapid generation of mature dendritic cells
ES2314099T3 (es)	2001-08-17	2009-03-16	Coley Pharmaceutical Gmbh	Oligonucleotidos inmunoestimulantes con motivos combinados con actividad mejorada.
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AR045702A1 (es)	2001-10-03	2005-11-09	Chiron Corp	Composiciones de adyuvantes.
AU2002366710A1 (en)	2001-12-20	2003-07-09	The Government Of The United States Of America As Represented By The Secretary Of The Department Of	USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
CA2388049A1 (en)	2002-05-30	2003-11-30	Immunotech S.A.	Immunostimulatory oligonucleotides and uses thereof
US7605138B2 (en)	2002-07-03	2009-10-20	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
JP2005532067A (ja) *	2002-07-03	2005-10-27	コーリーファーマシューティカルグループ，インコーポレイテッド	刺激性免疫応答用の核酸組成物
US7807803B2 (en)	2002-07-03	2010-10-05	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US7576066B2 (en)	2002-07-03	2009-08-18	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US7569553B2 (en)	2002-07-03	2009-08-04	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en)	2002-07-03	2004-03-18	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
CA2503693A1 (en)	2002-10-29	2004-05-13	Coley Pharmaceutical Group, Ltd.	Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
JP2006512927A (ja)	2002-12-11	2006-04-20	コーリーファーマシューティカルグループ，インコーポレイテッド	５’ｃｐｇ核酸およびその使用方法
ATE544772T1 (de)	2002-12-23	2012-02-15	Dynavax Tech Corp	Immunstimulierende sequenz-oligonukleotide und verwendungsverfahren dafür
US8158768B2 (en)	2002-12-23	2012-04-17	Dynavax Technologies Corporation	Immunostimulatory sequence oligonucleotides and methods of using the same
WO2005021726A2 (en) *	2003-08-28	2005-03-10	The Immune Response Corporation	Immunogenic hiv compositions and related methods
MY159370A (en)	2004-10-20	2016-12-30	Coley Pharm Group Inc	Semi-soft-class immunostimulatory oligonucleotides
CN101517082B (zh)	2006-09-27	2014-01-22	科勒制药有限责任公司	具有增强的免疫刺激活性的含疏水性T类似物的CpG寡聚核苷酸类似物
WO2010051820A1 (en) *	2008-11-10	2010-05-14	Aarhus Universitet	Multiplexed cytokine vaccination
AU2012280901B2 (en)	2011-07-06	2016-11-10	Glaxosmithkline Biologicals S.A.	Oil-in-water emulsions that contain nucleic acids
RU2649133C2 (ru)	2011-07-06	2018-03-29	Новартис Аг	Катионные эмульсии масло-в-воде

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998055495A2 (en) *	1997-06-06	1998-12-10	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU753688B2 (en) *	1997-03-10	2002-10-24	Ottawa Civic Loeb Research Institute	Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

2000
- 2000-05-05 AU AU49929/00A patent/AU4992900A/en not_active Abandoned
- 2000-05-05 AP APAP/P/2001/002300A patent/AP1891A/en active
- 2000-05-05 BR BR0010323-3A patent/BR0010323A/pt not_active IP Right Cessation
- 2000-05-05 WO PCT/US2000/012495 patent/WO2000067787A2/en not_active Ceased
- 2000-05-05 OA OA1200100291A patent/OA11937A/en unknown
- 2000-05-05 EP EP00932163A patent/EP1176978A2/en not_active Withdrawn
- 2000-05-05 CA CA002372960A patent/CA2372960C/en not_active Expired - Fee Related
2001
- 2001-10-25 CR CR6491A patent/CR6491A/es not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998055495A2 (en) *	1997-06-06	1998-12-10	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Vaccine, GB, Butterworth Scientific, Guildford, Vol. 16, No. 7, 1 *
Vaccine, Vol. 18, No. 11-12, 01/2000 *

Also Published As

Publication number	Publication date
CA2372960A1 (en)	2000-11-16
WO2000067787A3 (en)	2001-04-26
OA11937A (en)	2006-04-12
AP2001002300A0 (en)	2001-12-31
AU4992900A (en)	2000-11-21
EP1176978A2 (en)	2002-02-06
CA2372960C (en)	2006-03-28
BR0010323A (pt)	2002-01-08
WO2000067787A2 (en)	2000-11-16
CR6491A (es)	2005-05-31

Publication	Publication Date	Title
WO2000067787A3 (en)	2001-04-26	Hiv immunogenic compositions and methods
ES2272012T5 (es)	2010-07-06	Proteinas de fusion que comprenden las proteinas tat y/o nef del vih-1.
WO2005013918A3 (en)	2005-12-29	Compositions, methods and kits relating to poxvirus subunit vaccines
MXPA01011047A (es)	2003-10-14	Secuencias genomicas de neisseria y metodos para su uso.
MY129263A (en)	2007-03-30	Vaccine composition
MXPA03008715A (es)	2003-12-11	Reduccion de la inmunogenicidad de proteinas de fusion.
TW200621806A (en)	2006-07-01	Vaccine
WO2001053463A3 (en)	2002-02-14	COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES
NO20031646D0 (no)	2003-04-10	Ajuvantsammensetning omfattende et immunostimulatorisk oligonukleotid og entokol
MXPA01003557A (es)	2004-04-05	Secuencias genomicas de neisseria y metodos para su uso.
MXPA02005639A (es)	2004-09-10	Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico.
AU2001262345A1 (en)	2001-12-17	Antigenic composition comprising a polycationic peptide and inosine and cytosine
DK1104306T3 (da)	2006-05-22	Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
WO2004007679A3 (en)	2004-10-14	Dendritic cell pontentiation
ZA200500073B (en)	2006-02-22	Iscom preparation and use thereof.
MXPA04001224A (es)	2004-05-27	Agentes para incrementar la respuesta inmune.
ATE315404T1 (de)	2006-02-15	Influenzavirus-impfstoffzusammensetzung
ATE276758T1 (de)	2004-10-15	Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
CY1112139T1 (el)	2015-11-04	Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
AU2457100A (en)	2000-09-14	Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs
BR9712556A (pt)	1999-10-19	Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
MA32821B1 (fr)	2011-11-01	Vaccin combine notamment contre la coqueluche (vaccin cellulaire entier)
WO2005021726A3 (en)	2008-01-17	Immunogenic hiv compositions and related methods
TW200502245A (en)	2005-01-16	Vaccine
AU6078399A (en)	2000-04-17	Ligand presenting assembly (lpa), method of preparation and uses thereof